Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal Type
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Feasibility of Combined Genomics/Transcriptomics for Patients With Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Study of 6MW3211 Injection in the Treatment of Relapsed/Refractory Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT)
- Status
- RECRUITING
- Phase
- NA
A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE3
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
- Status
- RECRUITING
- Phase
- N/A
Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2
SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study Evaluating the Safety, Tolerability, Pharmacokinetic and Efficacy of HLX301(TIGIT×PDL1 Bispecific) in Locally Advanced/Metastatic Solid Tumors or Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Screening for Oculocerebral Lymphoma with the Phenotype of NK Cells in Patients with Uveitis
- Status
- RECRUITING
- Phase
- NA
Chemotherapy Induced Peripheral Neuropathy (CIPN) and Lymphoma Longitudinal Follow-up and Prognostic Factors
- Status
- COMPLETED
- Phase
- NA
Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)
- Status
- RECRUITING
- Phase
- PHASE1
Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Status
- RECRUITING
- Phase
- N/A
Companion for CAR-T Web App During Chimeric Antigen Receptor T-cell Therapy
- Status
- WITHDRAWN
- Phase
- NA
A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma（Keyplus-001）
- Status
- RECRUITING
- Phase
- PHASE1
Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1